Oric Pharmaceuticals, Inc. Common Stock
Symbol: ORIC (NASDAQ)
12.58
▲ (1.58%) 0.195
Company Description:
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
Key Stats
- Today's Open: $12.575
- Today's High: $12.575
- Today's Low: $12.575
- Today's Volume: 48
- Yesterday Close: $12.38
- Yesterday High: $13.07
- Yesterday Low: $12.37
- Yesterday Volume: 1.42M
- Last Min Volume: 15
- Last Min High: $12.575
- Last Min Low: $12.575
- Last Min VWAP: $12.575
Company Profile
- Name: Oric Pharmaceuticals, Inc. Common Stock
- Website: https://www.oricpharma.com
- Listed Date: 2020-04-24
- Location: SOUTH SAN FRANCISCO, CA
- Market Status: Active
- CIK Number: 0001796280
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $1.20B
- Round Lot: 100
- Outstanding Shares: 97.12M
- Asset Type: CS
RECENT FILINGS FOR ORIC
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-08 | 4 | View |
| 2025-10-08 | 4 | View |
| 2025-10-06 | 144 | View |
| 2025-10-03 | 4 | View |
| 2025-10-02 | 4 | View |
| 2025-09-24 | 4 | View |
| 2025-09-22 | 144 | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-14 | SCHEDULE 13D/A | View |
| 2025-08-12 | 10-Q | View |
| 2025-08-12 | 8-K | View |
| 2025-08-05 | SCHEDULE 13G | View |
| 2025-07-17 | SCHEDULE 13G/A | View |
| 2025-07-02 | 4 | View |
| 2025-06-24 | 4 | View |
| 2025-06-24 | 424B3 | View |
| 2025-06-23 | 4 | View |
| 2025-06-20 | EFFECT | View |
| 2025-06-17 | CORRESP | View |
Latest News on ORIC